Atlas Trials

Spanish Real World Data on Patients Treated With Durvalumab After Chemoradiotherapy.

Clinical trial NCT04285866 · COMPLETED

Trial details

NCT number
NCT04285866
Sponsor
Fundación GECP
Status
COMPLETED
Study type
OBSERVATIONAL
Small Cell Lung Cancer (SCLC)
Start date
2020-05-21
Primary completion
2021-12-31
Enrollment
245

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.